We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GTBP market cap is 759.35k. The company's latest EPS is USD -5.5025 and P/E is -0.57.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.46M | -6.76M | -57.52M | -21.26M | -13.58M |
| Net Income | -18.19M | -28.3M | -58.01M | -20.88M | -7.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 396k | 5.66M | 32.17M | 16.74M | 14.11M |
| Total Liabilities | 19.71M | 35.09M | 10.26M | 5M | 6.63M |
| Total Equity | -19.31M | -29.43M | 21.91M | 11.73M | 7.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.66M | -7.26M | -15.61M | -15.22M | -8.85M |
| Investing | 200k | N/A | -23.04M | 12.15M | -2.01M |
| Financing | 3.43M | 12.53M | 42.32M | -224k | 6.27M |
| Market Cap | 759.35k |
| Price to Earnings Ratio | -0.57 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.98 |
| Price to Book Ratio | 0.57 |
| Dividend Yield | - |
| Shares Outstanding | 1.38M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.07 (12.73%) |
| Company Name | Ordinary Shares |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.gtbiopharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
